Table 2 Demographic and clinical characteristics
Participants (N, %) | Â | Â |
|---|---|---|
Gender | Â | Â |
Male | 5 | 25 |
Female | 15 | 75 |
Age (years, SD) | 64 | 6.6 |
Location OA (N, %) | Â | Â |
Knee | 7 | 35 |
Hip | 5 | 25 |
Knee and hip | 8 | 40 |
Duration OA symptoms (years, SD) | 9.3 | 11.4 |
Participants (N, %) | Â | Â |
|---|---|---|
Gender | Â | Â |
Male | 5 | 25 |
Female | 15 | 75 |
Age (years, SD) | 64 | 6.6 |
Location OA (N, %) | Â | Â |
Knee | 7 | 35 |
Hip | 5 | 25 |
Knee and hip | 8 | 40 |
Duration OA symptoms (years, SD) | 9.3 | 11.4 |